148 related articles for article (PubMed ID: 36055539)
1. Albendazole-induced autophagy blockade contributes to elevated apoptosis in cholangiocarcinoma cells through AMPK/mTOR activation.
He Q; Yin Y; Pan X; Wu Y; Li X
Toxicol Appl Pharmacol; 2022 Nov; 454():116214. PubMed ID: 36055539
[TBL] [Abstract][Full Text] [Related]
2. Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.
Hu MH; Huang TT; Chao TI; Chen LJ; Chen YL; Tsai MH; Liu CY; Kao JH; Chen KF
Liver Int; 2018 Dec; 38(12):2248-2259. PubMed ID: 29797403
[TBL] [Abstract][Full Text] [Related]
3. Atractylodin inhibited the migration and induced autophagy in cholangiocarcinoma cells via PI3K/AKT/mTOR and p38MAPK signalling pathways.
Acharya B; Chaijaroenkul W; Na-Bangchang K
J Pharm Pharmacol; 2021 Aug; 73(9):1191-1200. PubMed ID: 33885818
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma.
Chen MH; Chiang KC; Cheng CT; Huang SC; Chen YY; Chen TW; Yeh TS; Jan YY; Wang HM; Weng JJ; Chang PM; Liu CY; Li CP; Chao Y; Chen MH; Huang CY; Yeh CN
Oncotarget; 2014 May; 5(9):2372-89. PubMed ID: 24796583
[TBL] [Abstract][Full Text] [Related]
5. Compound C induces protective autophagy in human cholangiocarcinoma cells via Akt/mTOR-independent pathway.
Zhao X; Luo G; Cheng Y; Yu W; Chen R; Xiao B; Xiang Y; Feng C; Fu W; Duan C; Yao F; Xia X; Tao Q; Wei M; Dai R
J Cell Biochem; 2018 Jul; 119(7):5538-5550. PubMed ID: 29384220
[TBL] [Abstract][Full Text] [Related]
6. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
[TBL] [Abstract][Full Text] [Related]
7. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.
Yothaisong S; Dokduang H; Techasen A; Namwat N; Yongvanit P; Bhudhisawasdi V; Puapairoj A; Riggins GJ; Loilome W
Tumour Biol; 2013 Dec; 34(6):3637-48. PubMed ID: 23832540
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways.
Viereckl MJ; Krutsinger K; Apawu A; Gu J; Cardona B; Barratt D; Han Y
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740979
[TBL] [Abstract][Full Text] [Related]
10. Artesunate and chloroquine induce cytotoxic activity on cholangiocarcinoma cells via different cell death mechanisms.
Guragain D; Seubwai W; Kobayashi D; Silsinivanit A; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Wongkham S; Araki N; Cha'on U
Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):113-118. PubMed ID: 30084802
[TBL] [Abstract][Full Text] [Related]
11. Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway.
Wandee J; Prawan A; Senggunprai L; Kongpetch S; Tusskorn O; Kukongviriyapan V
Life Sci; 2018 Aug; 207():172-183. PubMed ID: 29847773
[TBL] [Abstract][Full Text] [Related]
12. Perturbation of proteasome function by bortezomib leading to ER stress-induced apoptotic cell death in cholangiocarcinoma.
Vaeteewoottacharn K; Kariya R; Matsuda K; Taura M; Wongkham C; Wongkham S; Okada S
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1551-62. PubMed ID: 23877657
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal dysfunction and autophagy blockade contribute to autophagy-related cancer suppressing peptide-induced cytotoxic death of cervical cancer cells through the AMPK/mTOR pathway.
Yang Y; Wang Q; Song D; Zen R; Zhang L; Wang Y; Yang H; Zhang D; Jia J; Zhang J; Wang J
J Exp Clin Cancer Res; 2020 Sep; 39(1):197. PubMed ID: 32962728
[TBL] [Abstract][Full Text] [Related]
14. Antitumor Efficacy of the Herbal Recipe Benja Amarit against Highly Invasive Cholangiocarcinoma by Inducing Apoptosis both In Vitro and In Vivo.
Yapasert R; Lertprasertsuk N; Subhawa S; Poofery J; Sripanidkulchai B; Banjerdpongchai R
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784671
[TBL] [Abstract][Full Text] [Related]
15. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis.
Ma J; Weng L; Wang Z; Jia Y; Liu B; Wu S; Cao Y; Sun X; Yin X; Shang M; Mao A
Exp Cell Res; 2018 May; 366(2):103-113. PubMed ID: 29530475
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma.
Hou YJ; Dong LW; Tan YX; Yang GZ; Pan YF; Li Z; Tang L; Wang M; Wang Q; Wang HY
Lab Invest; 2011 Aug; 91(8):1146-57. PubMed ID: 21647092
[TBL] [Abstract][Full Text] [Related]
17. Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways.
Jaidee R; Kongpetch S; Senggunprai L; Prawan A; Kukongviriyapan U; Kukongviriyapan V
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1681-1690. PubMed ID: 32383028
[TBL] [Abstract][Full Text] [Related]
18. Phenformin inhibits cell proliferation and induces cell apoptosis and autophagy in cholangiocarcinoma.
Hu S; Ouyang Q; Cheng Q; Wang J; Feng F; Qiao L; Gan W; Shi Y; Wu D; Jiang X
Mol Med Rep; 2018 Apr; 17(4):6028-6032. PubMed ID: 29436644
[TBL] [Abstract][Full Text] [Related]
19. Blockade of chloride channel-3 enhances cisplatin sensitivity of cholangiocarcinoma cells though inhibiting autophagy.
Han Y; Zhou Y; Zhou L; Jia X; Yu X; An X; Shi Z
Can J Physiol Pharmacol; 2022 Jul; 100(7):584-593. PubMed ID: 35413227
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines.
Dokduang H; Jamnongkarn W; Promraksa B; Suksawat M; Padthaisong S; Thanee M; Phetcharaburanin J; Namwat N; Sangkhamanon S; Titapun A; Khuntikeo N; Klanrit P; Loilome W
Drug Des Devel Ther; 2020; 14():2319-2334. PubMed ID: 32606601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]